
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Upregulation of vasohibin-1 expression with angiogenesis and poor prognosis of hepatocellular carcinoma after curative surgery
Qizhi Wang, Xiangguo Tian, Chunqing Zhang, et al.
Medical Oncology (2011) Vol. 29, Iss. 4, pp. 2727-2736
Closed Access | Times Cited: 31
Qizhi Wang, Xiangguo Tian, Chunqing Zhang, et al.
Medical Oncology (2011) Vol. 29, Iss. 4, pp. 2727-2736
Closed Access | Times Cited: 31
Showing 1-25 of 31 citing articles:
A Systematic Review of Microvascular Invasion in Hepatocellular Carcinoma: Diagnostic and Prognostic Variability
Manuel Rodríguez‐Perálvarez, Tu Vinh Luong, Lorenzo Andreana, et al.
Annals of Surgical Oncology (2012) Vol. 20, Iss. 1, pp. 325-339
Closed Access | Times Cited: 578
Manuel Rodríguez‐Perálvarez, Tu Vinh Luong, Lorenzo Andreana, et al.
Annals of Surgical Oncology (2012) Vol. 20, Iss. 1, pp. 325-339
Closed Access | Times Cited: 578
Transcriptional landscape of human cancers
Mengyuan Li, Qingrong Sun, Xiaosheng Wang
Oncotarget (2017) Vol. 8, Iss. 21, pp. 34534-34551
Open Access | Times Cited: 88
Mengyuan Li, Qingrong Sun, Xiaosheng Wang
Oncotarget (2017) Vol. 8, Iss. 21, pp. 34534-34551
Open Access | Times Cited: 88
The vasohibin family: a novel family for angiogenesis regulation
Yasufumi Sato
The Journal of Biochemistry (2012) Vol. 153, Iss. 1, pp. 5-11
Open Access | Times Cited: 101
Yasufumi Sato
The Journal of Biochemistry (2012) Vol. 153, Iss. 1, pp. 5-11
Open Access | Times Cited: 101
Keratin 19 as a key molecule in progression of human hepatocellular carcinomas through invasion and angiogenesis
Masato Takano, Keiji Shimada, Tomomi Fujii, et al.
BMC Cancer (2016) Vol. 16, Iss. 1
Open Access | Times Cited: 52
Masato Takano, Keiji Shimada, Tomomi Fujii, et al.
BMC Cancer (2016) Vol. 16, Iss. 1
Open Access | Times Cited: 52
The prognostic significance of vasohibin 1–associated angiogenesis in patients with hepatocellular carcinoma
Keigo Murakami, Atsuko Kasajima, Naoki Kawagishi, et al.
Human Pathology (2013) Vol. 45, Iss. 3, pp. 589-597
Closed Access | Times Cited: 34
Keigo Murakami, Atsuko Kasajima, Naoki Kawagishi, et al.
Human Pathology (2013) Vol. 45, Iss. 3, pp. 589-597
Closed Access | Times Cited: 34
The roles of vasohibin and its family members: Beyond angiogenesis modulators
Hua Du, Jing Zhao, Ling Hai, et al.
Cancer Biology & Therapy (2017) Vol. 18, Iss. 11, pp. 827-832
Open Access | Times Cited: 31
Hua Du, Jing Zhao, Ling Hai, et al.
Cancer Biology & Therapy (2017) Vol. 18, Iss. 11, pp. 827-832
Open Access | Times Cited: 31
Exacerbation of Diabetic Renal Alterations in Mice Lacking Vasohibin-1
Norikazu Hinamoto, Yohei Maeshima, Hiroko Yamasaki, et al.
PLoS ONE (2014) Vol. 9, Iss. 9, pp. e107934-e107934
Open Access | Times Cited: 30
Norikazu Hinamoto, Yohei Maeshima, Hiroko Yamasaki, et al.
PLoS ONE (2014) Vol. 9, Iss. 9, pp. e107934-e107934
Open Access | Times Cited: 30
Mining distinct aldehyde dehydrogenase 1 (ALDH1) isoenzymes in gastric cancer
Jiaxin Shen, Jing Liu, Guanwu Li, et al.
Oncotarget (2016) Vol. 7, Iss. 18, pp. 25340-25349
Open Access | Times Cited: 26
Jiaxin Shen, Jing Liu, Guanwu Li, et al.
Oncotarget (2016) Vol. 7, Iss. 18, pp. 25340-25349
Open Access | Times Cited: 26
Vasohibin-1 expression detected by immunohistochemistry correlates with prognosis in non-small cell lung cancer
Tao Zhang, Tingting Yu, Dongming Zhang, et al.
Medical Oncology (2014) Vol. 31, Iss. 5
Closed Access | Times Cited: 25
Tao Zhang, Tingting Yu, Dongming Zhang, et al.
Medical Oncology (2014) Vol. 31, Iss. 5
Closed Access | Times Cited: 25
Tregs are involved in VEGFA/ VASH1-related angiogenesis pathway in ovarian cancer
Sijing Qiao, Yue Hou, Rong Qing, et al.
Translational Oncology (2023) Vol. 32, pp. 101665-101665
Open Access | Times Cited: 8
Sijing Qiao, Yue Hou, Rong Qing, et al.
Translational Oncology (2023) Vol. 32, pp. 101665-101665
Open Access | Times Cited: 8
Enhanced Cancer Metastasis in Mice Deficient in Vasohibin-1 Gene
Soichi Ito, Hiroki Miyashita, Yasuhiro Suzuki, et al.
PLoS ONE (2013) Vol. 8, Iss. 9, pp. e73931-e73931
Open Access | Times Cited: 25
Soichi Ito, Hiroki Miyashita, Yasuhiro Suzuki, et al.
PLoS ONE (2013) Vol. 8, Iss. 9, pp. e73931-e73931
Open Access | Times Cited: 25
Vasohibin-1 suppresses colon cancer
Shuai Liu, Bing Han, Qunyuan Zhang, et al.
Oncotarget (2015) Vol. 6, Iss. 10, pp. 7880-7898
Open Access | Times Cited: 24
Shuai Liu, Bing Han, Qunyuan Zhang, et al.
Oncotarget (2015) Vol. 6, Iss. 10, pp. 7880-7898
Open Access | Times Cited: 24
Reduced expression of vasohibin-1 is associated with clinicopathological features in renal cell carcinoma
Guangning Zhao, Yuming Yang, Yang Tang, et al.
Medical Oncology (2012) Vol. 29, Iss. 5, pp. 3325-3334
Closed Access | Times Cited: 23
Guangning Zhao, Yuming Yang, Yang Tang, et al.
Medical Oncology (2012) Vol. 29, Iss. 5, pp. 3325-3334
Closed Access | Times Cited: 23
Urinary and Plasma Levels of Vasohibin-1 Can Predict Renal Functional Deterioration in Patients with Renal Disorders
Norikazu Hinamoto, Yohei Maeshima, Daisuke Saito, et al.
PLoS ONE (2014) Vol. 9, Iss. 6, pp. e96932-e96932
Open Access | Times Cited: 18
Norikazu Hinamoto, Yohei Maeshima, Daisuke Saito, et al.
PLoS ONE (2014) Vol. 9, Iss. 6, pp. e96932-e96932
Open Access | Times Cited: 18
Novel Link between Inhibition of Angiogenesis and Tolerance to Vascular Stress
Yasufumi Sato
Journal of Atherosclerosis and Thrombosis (2015) Vol. 22, Iss. 4, pp. 327-334
Open Access | Times Cited: 17
Yasufumi Sato
Journal of Atherosclerosis and Thrombosis (2015) Vol. 22, Iss. 4, pp. 327-334
Open Access | Times Cited: 17
Proteolytic inactivation of anti-angiogenic vasohibin-1 by cancer cells
Megumu K. Saito, Yasuhiro Suzuki, Seiji Yano, et al.
The Journal of Biochemistry (2016) Vol. 160, Iss. 4, pp. 227-232
Open Access | Times Cited: 15
Megumu K. Saito, Yasuhiro Suzuki, Seiji Yano, et al.
The Journal of Biochemistry (2016) Vol. 160, Iss. 4, pp. 227-232
Open Access | Times Cited: 15
High preoperative plasma vasohibin‐1 concentration predicts better prognosis in patients with non–small cell lung carcinoma
Tatsuaki Watanabe, Tomoko Hosaka, Kaori Ohmori‐Matsuda, et al.
Health Science Reports (2018) Vol. 1, Iss. 6
Open Access | Times Cited: 12
Tatsuaki Watanabe, Tomoko Hosaka, Kaori Ohmori‐Matsuda, et al.
Health Science Reports (2018) Vol. 1, Iss. 6
Open Access | Times Cited: 12
Reversal of vasohibin-driven negative feedback loop of vascular endothelial growth factor/angiogenesis axis promises a novel antifibrotic therapeutic strategy for liver diseases
Suvro Chatterjee
Hepatology (2014) Vol. 60, Iss. 2, pp. 458-460
Open Access | Times Cited: 9
Suvro Chatterjee
Hepatology (2014) Vol. 60, Iss. 2, pp. 458-460
Open Access | Times Cited: 9
Vasohibin-1 inhibits angiogenesis and suppresses tumor growth in renal cell carcinoma
Guangning Zhao, Na Ren, Liming Li, et al.
Oncology Reports (2017) Vol. 38, Iss. 2, pp. 1021-1028
Open Access | Times Cited: 9
Guangning Zhao, Na Ren, Liming Li, et al.
Oncology Reports (2017) Vol. 38, Iss. 2, pp. 1021-1028
Open Access | Times Cited: 9
Renal distribution of Vasohibin-1 in patients with chronic kidney disease.
Norikazu Hinamoto, Yohei Maeshima, Daisuke Saito, et al.
PubMed (2014) Vol. 68, Iss. 4, pp. 219-33
Closed Access | Times Cited: 7
Norikazu Hinamoto, Yohei Maeshima, Daisuke Saito, et al.
PubMed (2014) Vol. 68, Iss. 4, pp. 219-33
Closed Access | Times Cited: 7
The correlation of the expressions of WWOX, LGR5 and vasohibin-1 in epithelial ovarian cancer and their clinical significance.
Lan Yu, Xu Mao, Shiwu Wu, et al.
PubMed (2019) Vol. 12, Iss. 1, pp. 327-336
Closed Access | Times Cited: 7
Lan Yu, Xu Mao, Shiwu Wu, et al.
PubMed (2019) Vol. 12, Iss. 1, pp. 327-336
Closed Access | Times Cited: 7
Clinical implications of vasohibin-1 in esophageal carcinoma cells: Inhibition of cell growth and migration
Deliang Ma, Jingye Li, Jinbao Wang, et al.
Molecular Medicine Reports (2017) Vol. 16, Iss. 2, pp. 1479-1485
Open Access | Times Cited: 6
Deliang Ma, Jingye Li, Jinbao Wang, et al.
Molecular Medicine Reports (2017) Vol. 16, Iss. 2, pp. 1479-1485
Open Access | Times Cited: 6
Association between TAp73, p53 and VASH1 expression in lung adenocarcinoma
Meng Wu, Zhihua Zhang, Fangxu Ma, et al.
Oncology Letters (2018)
Open Access | Times Cited: 3
Meng Wu, Zhihua Zhang, Fangxu Ma, et al.
Oncology Letters (2018)
Open Access | Times Cited: 3
Clinicopathological Role of Vasohibin in Gastroenterological Cancers: A Meta-Analysis
Miho Yamamoto, Soji Ozawa, Kazuo Koyanagi, et al.
The Tohoku Journal of Experimental Medicine (2022) Vol. 256, Iss. 4, pp. 291-301
Open Access | Times Cited: 2
Miho Yamamoto, Soji Ozawa, Kazuo Koyanagi, et al.
The Tohoku Journal of Experimental Medicine (2022) Vol. 256, Iss. 4, pp. 291-301
Open Access | Times Cited: 2
Comment and reply on: Vasohibin-1 and its emerging role in the evolution and progression of systemic tumors besides renal cell carcinomas
Shailendra Kapoor, Monica S. M. Chan, Lin Wang, et al.
Expert Opinion on Therapeutic Targets (2012) Vol. 17, Iss. 1, pp. 105-106
Open Access | Times Cited: 1
Shailendra Kapoor, Monica S. M. Chan, Lin Wang, et al.
Expert Opinion on Therapeutic Targets (2012) Vol. 17, Iss. 1, pp. 105-106
Open Access | Times Cited: 1